Politics White House and Pelosi part ways on relief for drug prices
Diplomat says top leadership of the State Department rejected his entreaties to publicly support ousted U.S. ambassador to Ukraine
Philip Reeker, head of the State Department bureau responsible for Europe, testified before House impeachment panel on Saturday.Reeker expressed his concerns over the falsehoods about Marie Yovanovitch in conversations with David Hale, the third-highest ranking official in the State Department, and T. Ulrich Brechbuhl, an adviser to Secretary of State Mike Pompeo whose friendship began when they attended U.S. Military Academy together, the person said. But it remains unclear how much information they conveyed to Pompeo, and what role he played in Yovanovitch’s recall shortly after she was told she was doing such a good job her posting was being extended.
WASHINGTON (AP) — The White House on Tuesday signaled President Donald Trump's blunt thumbs-down to House Speaker Nancy Pelosi's plan allowing Medicare to negotiate drug prices. Her office's sharp retort: "Working people won't like it if he sells them out."
Despite the House impeachment inquiry, the White House and top aides to the California Democrat have been in regular contact on efforts to curb drug prices, a mutual objective and a top concern for Americans across party lines.
What's Next: Depositions turn to the White House
For only the fourth time in U.S. history, the House of Representatives has started a presidential impeachment inquiry. House committees are trying to determine if President Donald Trump violated his oath of office by asking Ukraine to investigate political rival Joe Biden and his family, and to investigate the country's involvement in the 2016 U.S. presidential election. © Provided by The Associated Press FILE - In this Sept. 24, 2019, file photo, President Donald Trump addresses reporters as he arrives with first lady Melania Trump for the 74th session of the United Nations General Assembly, at U.N.
But a senior White House official told The Associated Press that the administration has concludedis "unworkable" and Trump will instead support bipartisan legislation pending in the Senate. The official spoke on condition of anonymity to discuss ongoing deliberations.
The falling out imperils chances for legislation this year, already seen as a long shot.
A recent study found more than half of seriously ill Medicare enrollees face financial hardships with medical bills, and prescription drug costs are the leading problem.
In a statement responding to the White House, Pelosi spokesman Henry Connelly said, "House Democrats are taking the bold action to negotiate lower drug prices that President Trump always claimed was necessary, and working people won't like it if he sells them out on one of the most important kitchen table issues in America right now."
How the Astros got their swagger back
WASHINGTON — Nearly half the room was filled with champions. Their rings, each studded with 25 natural sapphires and 214 diamonds, from 2017 still glimmered, if not in lock boxes, certainly in memories. They knew better than to feel as shaken as they had looked coming off the Minute Maid Park field last week. They were beleaguered from an embarrassing Game 2 loss that frittered away home-field advantage and put them down 2-0 in the World Series to the chest-pounding Washington Nationals, who were playing more like the Astros had two years ago.
The senior White House official said that while Trump is not ideologically opposed to Medicare negotiating prices for medicines, Pelosi's approach can't be quickly retooled.
Her bill would levy steep taxes on drugmakers who refuse to accept a Medicare price keyed to what's paid in other economically advanced countries. The White House official objected that Pelosi's bill is essentially structured to give Medicare the power to dictate prices, and pointed to its lack of Republican support.
Trump is backing a bipartisan bill from Sens. Charles Grassley, R-Iowa, and Ron Wyden, D-Ore.
That legislation would for the first time limit what seniors have to pay out of their own pockets for medications. It would also require drug companies to pay rebates to Medicare if they hike prices beyond the inflation rate.
Similar ideas are also in Pelosi's legislation, but she takes a more aggressive approach to inflation rebates and sets a lower out-of-pocket limit for Medicare recipients.
White House Ukraine Expert Sought to Correct Transcript of Trump Call
Lt. Col. Alexander S. Vindman, the top Ukraine expert on the National Security Council, told House impeachment investigators on Tuesday that the White House transcript of a July call between President Trump and Ukraine’s president omitted crucial words and phrases, and that his attempts to restore them failed, according to three people familiar with the testimony. The omissions, Colonel Vindman said, included Mr. Trump’s assertion that there were recordings of former Vice President Joseph R. Biden Jr. discussing Ukraine corruption, and an explicit mention by Ukraine’s president, Volodymyr Zelensky, of Burisma Holdings, the energy company whose board employed Mr.
Under the legislation that created Medicare's prescription drug program, price negotiations are handled privately by insurers and their pharmacy benefit managers. The Grassley-Wyden bill does not grant Medicare negotiating power.
Pelosi's bill has cleared key committees and is headed for the House floor, where it's expected to pass on a party-line vote. The nonpartisan Congressional Budget Office has estimated it would save Medicare $345 billion over seven years, and Democrats want to use some of that to expand benefits.
Aides to the House speaker say that her bill would give Trump precisely what he had asked for as a presidential candidate, when he broke with other Republicans to back negotiating authority for Medicare. House Democrats even echo Trump's longstanding complaint that other countries where medications cost less are taking advantage of the U.S.
The White House says the administration is working withon improving their bill, by adding special provisions to address the escalating cost of insulin, which is used to treat diabetes, and by exploring a monthly limit on out-of-pocket costs for Medicare recipients.
It's unclear if and when that bill would go to the Senate floor. The Congressional Budget Office estimates it would save Medicare $85 billion over 10 years.
Grassley's office said Tuesday that the senator spoke last week with White House officials, who underscored Trump's backing for the Senate bill.
"Growing support for the bipartisan Senate bill reflects the emerging consensus that it's the only path forward to lower prescription drug prices," said Grassley spokesman Michael Zona.
'What I said was accurate': Sen. Kennedy defends calling Pelosi 'dumb' .
Sen. John Kennedy defended himself for having called House Speaker Nancy Pelosi "dumb."Sen. John Kennedy defended himself for having called House Speaker Nancy Pelosi "dumb" during a Wednesday night rally with President Trump in Louisiana.
BIO President says House Speaker Pelosi's drug price bill could be a 'disaster' in bio innovation
BIO President Jim Greenwood sat down with Proactive at the 2019 BIO Investor Forum. Greenwood talks about how current legislation being introduced by ...
Speaker of the House Nancy Pelosi in Seattle to discuss medication pricing
The Democratic lawmaker hopes to enact policy to keep prescription prices low for all Americans.